1. Home
  2. PULM vs BNGO Comparison

PULM vs BNGO Comparison

Compare PULM & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • BNGO
  • Stock Information
  • Founded
  • PULM 2003
  • BNGO 2003
  • Country
  • PULM United States
  • BNGO United States
  • Employees
  • PULM N/A
  • BNGO N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PULM Health Care
  • BNGO Industrials
  • Exchange
  • PULM Nasdaq
  • BNGO Nasdaq
  • Market Cap
  • PULM 21.0M
  • BNGO 24.3M
  • IPO Year
  • PULM N/A
  • BNGO 2018
  • Fundamental
  • Price
  • PULM $7.10
  • BNGO $4.84
  • Analyst Decision
  • PULM
  • BNGO Hold
  • Analyst Count
  • PULM 0
  • BNGO 3
  • Target Price
  • PULM N/A
  • BNGO $1.00
  • AVG Volume (30 Days)
  • PULM 37.6K
  • BNGO 289.4K
  • Earning Date
  • PULM 03-27-2025
  • BNGO 03-04-2025
  • Dividend Yield
  • PULM N/A
  • BNGO N/A
  • EPS Growth
  • PULM N/A
  • BNGO N/A
  • EPS
  • PULM N/A
  • BNGO N/A
  • Revenue
  • PULM $10,005,000.00
  • BNGO $33,334,000.00
  • Revenue This Year
  • PULM N/A
  • BNGO N/A
  • Revenue Next Year
  • PULM $1.00
  • BNGO $6.18
  • P/E Ratio
  • PULM N/A
  • BNGO N/A
  • Revenue Growth
  • PULM 47.05
  • BNGO N/A
  • 52 Week Low
  • PULM $1.55
  • BNGO $4.75
  • 52 Week High
  • PULM $8.44
  • BNGO $81.00
  • Technical
  • Relative Strength Index (RSI)
  • PULM 62.30
  • BNGO 29.16
  • Support Level
  • PULM $6.84
  • BNGO $4.95
  • Resistance Level
  • PULM $8.14
  • BNGO $5.89
  • Average True Range (ATR)
  • PULM 0.39
  • BNGO 1.28
  • MACD
  • PULM 0.11
  • BNGO -0.56
  • Stochastic Oscillator
  • PULM 71.43
  • BNGO 5.07

About PULM Pulmatrix Inc.

Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: